Elmore Joshua S, Baumann Michael H
Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, United States.
Front Psychiatry. 2018 Feb 27;9:55. doi: 10.3389/fpsyt.2018.00055. eCollection 2018.
Naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) is a synthetic compound found in psychoactive "spice" products that activates cannabinoid receptors. Preclinical evidence suggests that exposure to synthetic cannabinoids increases 5-HT receptor function in the brain, an effect which might contribute to psychotic symptoms. Here, we hypothesized that repeated exposures to JWH-018 would enhance behavioral responsiveness to the 5-HT receptor agonist DOI. Male Sprague-Dawley rats fitted with subcutaneously (sc) temperature transponders received daily injections of JWH-018 (1.0 mg/kg, sc) or its vehicle for seven consecutive days. Body temperature and catalepsy scores were determined at 1, 2, and 4 h post-injection each day. At 1 and 7 days after the final repeated treatment, rats received a challenge injection of either DOI (0.1 mg/kg, sc) or the 5-HT receptor agonist 8-OH-DPAT (0.3 mg/kg, sc), then temperature and behavioral responses were assessed. Behaviors induced by DOI included wet dog shakes and back muscle contractions (i.e., skin jerks), while behaviors induced by 8-OH-DPAT included ambulation, forepaw treading, and flat body posture. On the first day of repeated treatment, JWH-018 produced robust hypothermia and catalepsy which lasted up to 4 h, and these effects were significantly blunted by day 7 of treatment. Repeated exposure to JWH-018 did not affect behaviors induced by DOI, but behavioral and hypothermic responses induced by 8-OH-DPAT were significantly augmented 1 day after cessation of JWH-018 treatment. Collectively, our findings show that repeated treatment with JWH-018 produces tolerance to its hypothermic and cataleptic effects, which is accompanied by transient enhancement of 5-HT receptor sensitivity .
萘-1-基-(1-戊基吲哚-3-基)甲酮(JWH-018)是一种在具有精神活性的“香料”产品中发现的合成化合物,可激活大麻素受体。临床前证据表明,接触合成大麻素会增加大脑中5-羟色胺(5-HT)受体功能,这种效应可能导致精神病症状。在此,我们假设重复接触JWH-018会增强对5-HT受体激动剂DOI的行为反应性。给雄性斯普拉格-道利大鼠皮下植入温度应答器,连续7天每日注射JWH-018(1.0毫克/千克,皮下注射)或其溶媒。每天在注射后1、2和4小时测定体温和僵住症评分。在最后一次重复治疗后的第1天和第7天,给大鼠注射DOI(0.1毫克/千克,皮下注射)或5-HT受体激动剂8-羟基二丙胺基四氢萘(8-OH-DPAT,0.3毫克/千克,皮下注射)进行激发注射,然后评估体温和行为反应。DOI诱导的行为包括湿狗样抖动和背部肌肉收缩(即皮肤抽搐),而8-OH-DPAT诱导的行为包括行走、前爪踩踏和平躺姿势。在重复治疗的第一天,JWH-018产生强烈的体温过低和僵住症,持续长达4小时,而在治疗第7天时这些效应明显减弱。重复接触JWH-018不影响DOI诱导的行为,但在停止JWH-018治疗1天后,8-OH-DPAT诱导的行为和体温过低反应显著增强。总体而言,我们的研究结果表明,重复用JWH-018治疗会使其体温过低和僵住症效应产生耐受性,同时伴有5-HT受体敏感性的短暂增强。